Cambiar Investors LLC decreased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 9.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 309,210 shares of the medical instruments supplier’s stock after selling 31,024 shares during the period. Cambiar Investors LLC owned approximately 0.16% of DENTSPLY SIRONA worth $5,869,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in the stock. Savant Capital LLC increased its position in shares of DENTSPLY SIRONA by 71.9% during the fourth quarter. Savant Capital LLC now owns 83,062 shares of the medical instruments supplier’s stock worth $1,577,000 after acquiring an additional 34,750 shares in the last quarter. Canvas Wealth Advisors LLC increased its position in shares of DENTSPLY SIRONA by 126.5% during the fourth quarter. Canvas Wealth Advisors LLC now owns 326,298 shares of the medical instruments supplier’s stock worth $6,245,000 after acquiring an additional 182,234 shares in the last quarter. Entropy Technologies LP bought a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth $630,000. Choreo LLC increased its position in shares of DENTSPLY SIRONA by 191.6% during the fourth quarter. Choreo LLC now owns 23,507 shares of the medical instruments supplier’s stock worth $440,000 after acquiring an additional 15,446 shares in the last quarter. Finally, OLD National Bancorp IN increased its position in shares of DENTSPLY SIRONA by 45.3% during the fourth quarter. OLD National Bancorp IN now owns 18,874 shares of the medical instruments supplier’s stock worth $358,000 after acquiring an additional 5,884 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.
DENTSPLY SIRONA Trading Down 1.6 %
Shares of XRAY opened at $18.46 on Tuesday. The firm has a 50-day moving average of $19.09 and a 200-day moving average of $22.13. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA Inc. has a one year low of $17.21 and a one year high of $34.91.
DENTSPLY SIRONA Dividend Announcement
Wall Street Analyst Weigh In
A number of research firms recently weighed in on XRAY. Barrington Research decreased their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Mizuho began coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 target price for the company. Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday. Finally, Robert W. Baird decreased their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research report on Friday, November 8th. Nine analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $26.33.
Get Our Latest Research Report on XRAY
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Articles
- Five stocks we like better than DENTSPLY SIRONA
- Business Services Stocks Investing
- Merck: 4 No-Brainer Reasons to Buy This Dip
- How Technical Indicators Can Help You Find Oversold Stocks
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- High Flyers: 3 Natural Gas Stocks for March 2022
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.